| The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells K Mestermann, T Giavridis, J Weber, J Rydzek, S Frenz, T Nerreter, ... Science translational medicine 11 (499), eaau5907, 2019 | 383 | 2019 |
| Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer M Luu, Z Riester, A Baldrich, N Reichardt, S Yuille, A Busetti, M Klein, ... Nature communications 12 (1), 4077, 2021 | 266 | 2021 |
| CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib H Jetani, I Garcia-Cadenas, T Nerreter, S Thomas, J Rydzek, JB Meijide, ... Leukemia 32 (5), 1168-1179, 2018 | 173 | 2018 |
| ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models L Wallstabe, C Göttlich, LC Nelke, J Kühnemundt, T Schwarz, T Nerreter, ... JCI insight 4 (18), 2019 | 161 | 2019 |
| Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T T Nerreter, S Letschert, R Götz, S Doose, S Danhof, H Einsele, M Sauer, ... Nature communications 10 (1), 3137, 2019 | 138 | 2019 |
| Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab E García-Guerrero, R Götz, S Doose, M Sauer, A Rodríguez-Gil, ... Leukemia 35 (1), 201-214, 2021 | 52 | 2021 |
| Mining naive rabbit antibody repertoires by phage display for monoclonal antibodies of therapeutic utility H Peng, T Nerreter, J Chang, J Qi, X Li, P Karunadharma, GJ Martinez, ... Journal of molecular biology 429 (19), 2954-2973, 2017 | 51 | 2017 |
| Chimeric antigen receptor library screening using a novel NF-κB/NFAT reporter cell platform J Rydzek, T Nerreter, H Peng, S Jutz, J Leitner, P Steinberger, H Einsele, ... Molecular Therapy 27 (2), 287-299, 2019 | 44 | 2019 |
| CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B* 35 control Epstein-Barr virus-associated lymphoproliferation AC Dragon, K Zimmermann, T Nerreter, D Sandfort, J Lahrberg, S Klöß, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 35 | 2020 |
| CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models M Seif, TK Kakoschke, F Ebel, MM Bellet, N Trinks, G Renga, M Pariano, ... Science Translational Medicine 14 (664), eabh1209, 2022 | 32 | 2022 |
| Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose-and time-dependent manner J Lohmeyer, T Nerreter, J Dotterweich, H Einsele, R Seggewiss-Bernhardt Clinical & Experimental Immunology 193 (1), 64-72, 2018 | 27 | 2018 |
| Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia. S Prommersberger, H Jetani, S Danhof, R Monjezi, T Nerreter, ... Current Research in Translational Medicine 66 (2), 37-38, 2018 | 27 | 2018 |
| Karanjin interferes with ABCB1, ABCC1, and ABCG2 M Michaelis, F Rothweiler, T Nerreter, M Sharifi, T Ghafourian, J Cinatl Journal of Pharmacy & Pharmaceutical Sciences 17 (1), 92-105, 2014 | 26 | 2014 |
| Differential effects of the oncogenic BRAF inhibitor PLX4032 (vemurafenib) and its progenitor PLX4720 on ABCB1 function M Michaelis, F Rothweiler, T Nerreter, M Van Rikxoort, M Sharifi, M Wiese, ... Journal of Pharmacy & Pharmaceutical Sciences 17 (1), 154-168, 2014 | 23 | 2014 |
| ROR1-targeting switchable CAR-T cells for cancer therapy H Peng, T Nerreter, K Mestermann, J Wachter, J Chang, M Hudecek, ... Oncogene 41 (34), 4104-4114, 2022 | 14 | 2022 |
| Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression M Michaelis, F Rothweiler, T Nerreter, M van Rikxoort, R Zehner, ... BMC research notes 7, 1-7, 2014 | 14 | 2014 |
| Dasatinib enhances migration of monocyte-derived dendritic cells by reducing phosphorylation of inhibitory immune receptors Siglec-9 and Siglec-3 T Nerreter, C Köchel, D Jesper, I Eichelbrönner, E Putz, H Einsele, ... Experimental Hematology 42 (9), 773-782. e3, 2014 | 13 | 2014 |
| Antibody‐Based CAR T Cells Produced by Lentiviral Transduction S Prommersberger, M Hudecek, T Nerreter Current Protocols in Immunology 128 (1), e93, 2020 | 12 | 2020 |
| Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro T Nerreter, E Distler, C Köchel, H Einsele, W Herr, ... Experimental Hematology 41 (7), 604-614. e4, 2013 | 7 | 2013 |
| FLT3 inhibitor treatment increases FLT3 expression that exposes FLT3-ITD+ AML blasts to elimination by FLT3 CAR-T cells H Jetani, I García-Cadenas, T Nerreter, R Goetz, J Sierra, H Bonig, ... Blood 132, 903, 2018 | 5 | 2018 |
Markus SauerUniversität WürzburgVerified email at uni-wuerzburg.de
